OMGA Liquidating, Inc. (f/k/a Omega Therapeutics, Inc.) Bankruptcy Docket

Cases

Plan effective Aug 8, 2025

Updated Oct 21, 7:56 PM ET

Petition filed
Feb 10, 2025
Plan confirmed
Jul 31, 2025

OMGA Liquidating remains in post-confirmation liquidation, with its October 21, 2026 post-confirmation report Dkt. 479 marked nonfinal. Claims reconciliation and distribution administration remain the operative work, and the next material deadline is November 2, 2026, for claims objections under the court’s extension order Dkt. 464.

Case docket on PACER

Research this case

Search available documents for this case. Full docket access requires Pro.

Open case research

Our analysis

Omega Therapeutics: $14M Chapter 11 Sale After $532M Deal · Mar 6, 2026

Key firms

Morris, Nichols, Arsht & Tunnell LLPBankruptcy Counsel
Cole Schotz P.C.Bankruptcy Counsel
Portage Point PartnersFinancial Advisor
Dundon Advisers LLCFinancial Advisor
Portage Point (Triple P RTS, LLC and Triple P Securities, LLC)Investment Banker

Recent filings

Oct 21Quarterly Post-Confirmation ReportBankr. D. Del., No. 25-10211, ECF No. 479View on PACERDkt. 479
Jul 23Final Notice of Unclaimed DistributionsBankr. D. Del., No. 25-10211, ECF No. 476View on PACERDkt. 476
Jul 16Post-Confirmation ReportBankr. D. Del., No. 25-10211, ECF No. 475View on PACERDkt. 475
Jul 8Quarterly Claims RegisterBankr. D. Del., No. 25-10211, ECF No. 474View on PACERDkt. 474
Jun 2Receipt of filing fee for Transfer/Assignment of Claim - Ch 11 with Claims Agent Assigned( 25-10211-BLS) (claims,trclm11) ( 28.00). Receipt Number A12692538, amount $ 28.00. (No Underlying Document) Attachments: Related:Bankr. D. Del., No. 25-10211, ECF No. 472Dkt. 472
Jun 2Transfer of Claim 88Bankr. D. Del., No. 25-10211, ECF No. 471View on PACERDkt. 471

Full docket (479) →

Case facts and filing dates come from court records.

Plan effective Aug 8, 2025

Updated Oct 21, 7:56 PM ET

Petition filed
Feb 10, 2025
Plan confirmed
Jul 31, 2025

Case docket on PACER

Research this case

Search available documents for this case. Full docket access requires Pro.

Open case research

Our analysis

Omega Therapeutics: $14M Chapter 11 Sale After $532M Deal · Mar 6, 2026

Key firms

Morris, Nichols, Arsht & Tunnell LLPBankruptcy Counsel
Cole Schotz P.C.Bankruptcy Counsel
Portage Point PartnersFinancial Advisor
Dundon Advisers LLCFinancial Advisor
Portage Point (Triple P RTS, LLC and Triple P Securities, LLC)Investment Banker

Recent filings

Oct 21Quarterly Post-Confirmation ReportBankr. D. Del., No. 25-10211, ECF No. 479View on PACERDkt. 479
Jul 23Final Notice of Unclaimed DistributionsBankr. D. Del., No. 25-10211, ECF No. 476View on PACERDkt. 476
Jul 16Post-Confirmation ReportBankr. D. Del., No. 25-10211, ECF No. 475View on PACERDkt. 475
Jul 8Quarterly Claims RegisterBankr. D. Del., No. 25-10211, ECF No. 474View on PACERDkt. 474
Jun 2Receipt of filing fee for Transfer/Assignment of Claim - Ch 11 with Claims Agent Assigned( 25-10211-BLS) (claims,trclm11) ( 28.00). Receipt Number A12692538, amount $ 28.00. (No Underlying Document) Attachments: Related:Bankr. D. Del., No. 25-10211, ECF No. 472Dkt. 472
Jun 2Transfer of Claim 88Bankr. D. Del., No. 25-10211, ECF No. 471View on PACERDkt. 471

Full docket (479) →

Case facts and filing dates come from court records.